title: [Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years].
abstract: Estimating cardiovascular risk with SCORE is not recommended in persons over 65 years. SCORE investigators have recently published specific tables for older people (SCORE Older Persons [SCORE OP]). The aim of this study is to assess the impact of using SCORE OP tables on a Spanish population aged over 64 years, and compare it with the use of SCORE in patients aged 65-69 years.
  
  
  
  Cross-sectional study carried out in 2 urban primary health care centres. Individuals between 65 and 85 years old without diabetes or established cardiovascular diseases were included. Cardiovascular risk using SCORE and the new SCORE OP tables for low risk countries was calculated.
  
  
  
  Cardiovascular risk was estimated in 3,425 patients. Mean values of the original SCORE and SCORE OP were 4.08 and 3.83, respectively in the group of patients aged 65-69 years old (n=974, 22.44%) (P< .001). The percentage of patients at high or very high risk was 25.46% and 22.90% with the original SCORE and the SCORE OP, respectively (P<.001). Using the original SCORE, 16.43% of the total patients should potentially be treated with lipid lowering drugs, while using the SCORE OP, 13.45% of the patients aged 65-69 years should potentially be treated. Using SCORE OP in patients older than 69 years, 61.49% patients should potentially be treated with lipid lowering drugs.
  
  
  
  SCORE OP identifies fewer patients at high or very high risk than the original SCORE, therefore, its utilization would imply treating fewer patients of this age with lipid lowering drugs.
authors: Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España; Unidad Docente ACEBA, Barcelona, España. Electronic address: cbrotons@eapsardenya.cat.
authors: Carlos
authors: C
authors: Brotons
authors: Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España; Unidad Docente ACEBA, Barcelona, España.
authors: Irene
authors: I
authors: Moral
authors: Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España; Unidad Docente ACEBA, Barcelona, España.
authors: Diana
authors: D
authors: Fernández
authors: Unidad Docente ACEBA, Barcelona, España; Equip d'Atenció Primària Dreta de l'Eixample, Barcelona, España.
authors: Lluis
authors: L
authors: Cuixart
authors: Unidad Docente ACEBA, Barcelona, España; Equip d'Atenció Primària Dreta de l'Eixample, Barcelona, España.
authors: Alex
authors: A
authors: Muñoz
authors: Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España; Unidad Docente ACEBA, Barcelona, España.
authors: Anna
authors: A
authors: Soteras
authors: Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España; Unidad Docente ACEBA, Barcelona, España.
authors: Mireia
authors: M
authors: Puig
authors: Unidad Docente ACEBA, Barcelona, España; Equip d'Atenció Primària Dreta de l'Eixample, Barcelona, España.
authors: Xavier
authors: X
authors: Joaniquet
authors: Unidad de Investigación, Equip d'Atenció Primària Sardenya, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España; Unidad Docente ACEBA, Barcelona, España.
authors: Albert
authors: A
authors: Casasa
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D011320:Primary Health Care; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Cardiovascular risk; Elderly; Mayores; Prevención primaria; Primary prevention; Riesgo cardiovascular; SCORE